Search clinical trials for: Early MMF to everolimus conversion

Total 477680 results

Dartmouth-Hitchcock Medical Center

Completed

Presurgical Treatment With Letrozole in Patients With Early-stage Breast Cancer.

Breast Cancer

United States
Assistance Publique - Hôpitaux de Paris
Novartis

Completed

The Efficacy of Everolimus in Reducing Total Native Kidney Volume in Polycystic Kidney Disease Transplanted Recipients (EVERKYSTE)

Autosomal Dominant Polycystic Kidney Disease

France
Novartis Pharmaceuticals

Completed

A Study Investigating the Renal Tolerability, Efficacy, and Safety of a CNI-free Versus a Standard Regimen in de Novo Heart Transplant (HTx) Recipients (MANDELA)

Heart Transplantation

Germany
Novartis Pharmaceuticals

Withdrawn

Study of the Effect of Everolimus Immunosuppressive Combination Therapies on Renal Function When Used as a Maintenance Treatment for Liver Transplant Patients. (Prometheus)

Liver Transplantation
Postgraduate Institute of Medical Education and...

Completed

Study to Compare the Efficacy of Mycophenolate Mofetil in Systemic Sclerosis Related Early Interstitial Lung Disease (MYILD)

Systemic Sclerosis | Interstitial Lung Disease | Scleroderma

India
Hospital Vall d'Hebron

Completed

The Impact of Everolimus Based Immunosuppression in the Evolution of Hepatitis C Fibrosis After Liver Transplantation

Hepatitis C Recurrence After Liver Transplant

Spain
Hennepin Healthcare Research Institute
American Heart Association

Completed

Cardiovascular Prevention for Persons With HIV

HIV Infection | Cardiovascular Disease Risk

United States
Kobe University

Unknown

Multicenter Comparison of Early and Late Vascular Responses to Everolimus-eluting Cobalt-CHromium Stent

Coronary Artery Disease

Japan
All India Institute of Medical Sciences, New Delhi
University of Cape Town; Sri Venkateswara Institute of Medical Sciences University

Completed

Intensive Smoking-cessation Intervention Versus Smoking-cessation Advice in Smear-positive Patients With Pulmonary Tuberculosis

Tuberculosis

India
Avraham Pharmaceuticals Ltd

Completed

A 3 Year Study to Evaluate the Safety and Efficacy of Low Dose Ladostigil in Patients With Mild Cognitive Impairment

Dementia | Mild Cognitive Impairment

Germany, Austria, Israel
Novartis Pharmaceuticals

Completed

12 Month Athena Study: Everolimus vs. Standard Regimen in de Novo Kidney Transplant Patients (ATHENA)

Kidney Transplantation | Renal Transplantation

Germany, France
Novartis Pharmaceuticals

Withdrawn

Immediate Conversion From Tacrolimus to Everolimus in Stable Maintenance Renal Transplant Recipients (HERMES)

Kidney Transplantation

Switzerland
Nair, Vinay, D.O.
Bristol-Myers Squibb; Icahn School of Medicine at Mount Sinai

Unknown

Early Conversion From CNI to Belatacept in Renal Transplant Recipients With Delayed and Slow Graft Function

Kidney Transplant | Delayed Graft Function

United States
Ege University

Completed

Conversion From Sirolimus to Everolimus in the Maintenance Treatment of Liver Transplant Recipients

Liver Transplant Recipients

Turkey
Novartis

Completed

Conversion Trial From Mycophenolate Mofetil (MMF) to Enteric-coated Mycophenolate Sodium (EC-MPS) in Stable Transplanted Patients Suffering From Gastrointestinal (GI) Adverse Events While on Mycophenolate Mofetil Therapy (MMF) Therapy

Liver Transplantation | Kidney Transplantation

Switzerland
Novartis Pharmaceuticals

Completed

Feasibility and Safety of Early Switch to Everolimus From Cyclosporine in de Novo Renal Transplant Patients

De Novo Renal Transplantation

Norway
Hyogo Brain and Heart Center

Unknown

Multicenter Registry of Very Early and Late Clinical Outcomes to Everolimus-eluting Cobalt-Chromium Stent In Patients With ST Elevation Myocardial Infarction (XIENCE STEMI)

STEMI | ST-elevation Acute Myocardial Infarction

Japan
Novartis Pharmaceuticals

Completed

A National Multi-center Randomized, Open Label Study to Evaluate Efficacy and Safety of Everolimus With EC-MPS Compared to Standard Treatment Combination Tacrolimus and EC-MPS in de Novo Liver Transplant Recipients (SIMCER)

Liver Transplantation

France
St. Joseph's Hospital and Medical Center, Phoenix

Terminated

Mycophenolate Mofetil (MMF) in Patients With IgA Nephropathy

IgA Nephropathy

United States
Instituto de Urologia e Nefrologia

Unknown

Effects of Everolimus in Left Ventricular Hypertrophy After Conversion From Azathioprine: A Pilot Study

Left Ventricular Hypertrophy

Brazil
Novartis Pharmaceuticals

Completed

SCHEDULE - Scandinavian Heart Transplant Everolimus de Novo Study With Early Calcineurin Inhibitor (CNI) Avoidance (SCHEDULE)

Renal Function and Chronic Allograft Vasculopathy

Norway, Denmark, Sweden
Irmandade Santa Casa de Misericórdia de Porto Alegre
Novartis

Completed

A Prospective Study to Investigate Mycophenolic Acid (MPA) Exposure Through Area Under the Curve (AUC) in Renal Transplants Recipients Treated With Mycophenolate Mofetil (MMF) and After Conversion to Mycophenolate Sodium (EC-MPS) (AUC-MPA)

Renal Transplantation

Brazil
Northwestern University
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK); Juvenile...

Terminated

PREVENTKD (Prevent Risks by Early interVEntion at Nighttime in Type 1 Diabetes for Kidney Disease) (PREVENTKD)

Type 1 Diabetes

United States
Maisonneuve-Rosemont Hospital
Novartis

Completed

Prospective, 6 Month, Open Label, Conversion Study From Mycophenolate Mofetil (MMF) to PRMYFORTIC*

Late Complication From Kidney Transplant

Canada
Astellas Pharma Inc
Astellas Pharma Canada, Inc.

Completed

Benefit of Early Protocol Biopsy and Treatment of Subclinical Rejection

Kidney Transplantation

Canada, United States
Novartis Pharmaceuticals

Completed

Efficacy and Safety of Everolimus+EC-MPS After Early CNI Elimination vs EC-MPS +Tacrolimus in Renal Transplant Recipients

Chronic Renal Failure

Israel
Yonsei University

Completed

Safety and Efficacy of the Early Introduction of Everolimus (Certican®) With Low Dose of Cyclosporine in de Novo Kidney Recipients After 1 Month of Transplantation

Planned Kidney Transplantation

Korea, Republic of
Yonsei University

Completed

Early Effects of Intensive Lipid Lowering Treatment With Ezetimibe/ Simvastatin (Vytorin®) Assessed by Virtual Histology-Intravascular Ultrasound (VH-IVUS) and Optical Coherence Tomography (OCT) on Plaque Characteristics in Patients With Acute Coronary Syndrome

Acute Coronary Syndrome

Korea, Republic of
Emory University
Genentech, Inc.

Terminated

Early Conversion From Tacrolimus to Efalizumab Maintenance Therapy in Kidney Transplant Recipients

Kidney Transplantation | Chronic Kidney Failure

United States
Pfizer

Terminated

Study Comparing Effect On Carotid Atherosclerosis Following Conversion From Tacrolimus To Sirolimus Post-Transplant In Kidney Transplant Patients

Atherosclerosis | Kidney Failure

Canada, United States
Fundação Pró Rim

Unknown

Evaluation of Early Use of Everolimus (EVE) on Cytomegalovirus (CMV) Infection in Renal Transplant Recipients

Cytomegalovirus Infections
Novartis

Completed

Concentration Controlled Everolimus With Reduced Dose Cyclosporine Versus Mycophenolate Mofetil With Standard Dose Cyclosporine in de Novo Renal Transplant Adult Recipients Treated With Basiliximab and Corticosteroids

Kidney Transplantation

Japan
Helio Tedesco Silva Junior
Pfizer

Completed

Planned Conversion From TAC to SRL-based Regimen in de Novo Kidney Transplant Recipients

Kidney Transplant

Brazil
Atrial Fibrillation Network
German Federal Ministry of Education and Research

Withdrawn

KONVERT-AF - Relevance of Point in Time for Conversion of Acute Atrial Fibrillation

Atrial Fibrillation

Germany
Assistance Publique - Hôpitaux de Paris

Terminated

Angiotensin-converting Enzyme Inhibitors and Early Sickle Cell Renal Disease in Children (MADREPIEC)

Sickle Cell Disease

France
Teva Branded Pharmaceutical Products R&D, Inc.

Completed

Evaluate Early Glatiramer Acetate Treatment in Delaying Conversion to Clinically Definite Multiple Sclerosis of Subjects Presenting With Clinically Isolated Syndrome (PreCISe)

Multiple Sclerosis
Hospital de Clinicas de Porto Alegre

Unknown

A Clinical Trial to Assess the Efficacy and Safety of the Conversion to Everolimus

Kidney Transplant Recipients

Brazil
Pontificia Universidad Catolica de Chile

Unknown

Search for Transcriptional Biomarkers in a Conversion Protocol From Calcineurin Inhibitors to Mycophenolate Mofetil (TBCP)

Liver Transplantation | Gene Expression | Immunosuppression Conversion

Chile
Yonsei University

Unknown

The Beneficial Role of Percutaneous Coronary Intervention Over Optimal Medical Therapy in Elderly Patients With Coronary Artery Disease (BRAVE)

Coronary Artery Disease

Korea, Republic of
Astellas Pharma Inc

Completed

A Study to Compare Early Steroid Withdrawal and Long-Term Steroid Maintenance Therapy in Kidney Transplant Patients

Renal Transplantation

United States
Novartis

Terminated

Antialbuminuric Effects of Valsartan and Lisinopril

Hypertension | Early Diabetic Nephropathy

Switzerland
University of Bologna

Completed

Harmonic in Laparoscopic Cholecystectomy for Acute Cholecystitis (HAC)

Cholecystitis

Italy
Rabin Medical Center

Completed

Everolimus and Low Dose CNI Compared With MMF and Full CNI Dose in Heart Transplanted Patients: One Year Follow up (CRAD001AILO2)

Chronic Rejection of Cardiac Transplant

Israel
Federal University of São Paulo

Unknown

Comparison of Two Immunosuppressive Regimens in Kidney Transplant Recipients With Deceased Donors With the Aim of Preventing the Development of Fibrosis / Atrophy of Reducing the Incidence of Cytomegalovirus Infection

Cytomegalovirus Infections | Disorder of Transplanted Kidney

Brazil
Novartis Pharmaceuticals

Completed

Efficacy and Safety of Early Versus Delayed Administration of Everolimus in de Novo Renal Transplant Patients

Renal Transplantation

Switzerland
Novartis

Completed

Clinical Study to Evaluate the Tolerability, Safety and Efficacy of Enteric-coated Mycophenolate Sodium After Equimolar Conversion From Mycophenolate Mofetil (MMF) in Patients With Renal Transplant

Prevention of Acute Rejection After Kidney Transplantation
Novartis

Completed

Clinical Study to Evaluate the Tolerability, Safety and Efficacy of Enteric-coated Mycophenolate Sodium, After Equimolar Conversion From Mycophenolate Mofetil (MMF), in Patients With Stable Renal Transplant Receiving Tacrolimus

Prevention of Acute Rejection After Kidney Transplantation
Chinese University of Hong Kong

Completed

Treatment of Early Immunoglobulin A Nephropathy by Angiotensin Converting Enzyme Inhibitor - A Randomized Controlled Trial

Normal Blood Pressure | Biopsy-confirmed IgA Nephropathy | Proteinuria Less Than 0.5 g Per Day | Serum Creatinine Below 120 Umol/l

Hong Kong
University Hospital, Basel, Switzerland
Novartis

Completed

An Open, Single Centre, Randomised, Parallel Group Study to Investigate Three Different Immunosuppressive Regimens (SterFreePlus)

Immunosuppressive Agents | Comparative Study

Switzerland
Hospital Arnau de Vilanova
Pfizer

Unknown

Early Detection of Atherosclerosis: a Randomized Trial in the Primary Prevention of Cardiovascular Diseases. (PRIMARIA)

Cardiovascular Diseases | Atherosclerosis

Spain

3

Subscribe